Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3394 Injection, lovotibeglogene autotem

J Codes (Drugs)

Also known as: lovotibeglogene autotemcel, gene therapy

Lovotibeglogene autotemcel gene therapy injection is treatment for severe combined immunodeficiency using modified autologous T cells.

In Plain Language

immune system gene therapy; severe immunodeficiency treatment

Clinical Context

Gene therapy for severe combined immunodeficiency using genetically modified patient T cells. Autologous T cells engineered to express functional adenosine deaminase. Intravenous administration.

RVU Information

CPT J3394 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

ImmunologyHematologyGene Therapy

Frequently Asked Questions

What is CPT code J3394?

CPT J3394 (Injection, lovotibeglogene autotem) is a J Codes (Drugs) code. Lovotibeglogene autotemcel gene therapy injection is treatment for severe combined immunodeficiency using modified autologous T cells.

How is J3394 administered?

CPT J3394 is administered by a healthcare provider, typically via injection or infusion. Gene therapy for severe combined immunodeficiency using genetically modified patient T cells. Autologous T cells engineered to express functional adenosine deaminase. Intravenous administration. It is used by Immunology, Hematology, Gene Therapy.

When is CPT J3394 used?

Gene therapy for severe combined immunodeficiency using genetically modified patient T cells. Autologous T cells engineered to express functional adenosine deaminase. Intravenous administration.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.